CIK 0001994702
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831365441
- Phone
- +1 510-925-2492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Technology Officer acquired 9,636 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 18,016 shares (option exercise)
- 4 Open-market buy 10% owner bought 253,136 shares at $22.00 ($5,568,992)
- 4 Conversion Director acquired 4,523,924 shares (conversion)
- 4 Conversion Director acquired 4,523,924 shares (conversion)
- 4 Conversion 10% owner acquired 4,523,924 shares (conversion)
- 4 Open-market buy 10% owner bought 450,000 shares at $22.00 ($9,900,000)
- 4 Open-market buy 10% owner bought 910,000 shares at $22.00 ($20,020,000)
- 4 Open-market buy Former 10% Owner bought 450,000 shares at $22.00 ($9,900,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 4 · 68 filings